| [1] |
Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014[J]. CA Cancer J Clin,2014,64(1):9-29.
|
| [2] |
Veronesi U,Viale G,Paganelli G,et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study[J].Ann Surg,2010,251(4):595-600.
|
| [3] |
Joyce DP, Manning A, Carter M,et al. Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer[J]. Breast Cancer Res Treat,2015,153(2):235-240.
|
| [4] |
DiSipio T, Rye S, Newman B,et al. Incidence of unilateral arm lymphoedema after breast cancer:a systematic review and meta-analysis[J]. Lancet Oncol,2013,14(6):500-515.
|
| [5] |
朱倩男,夏添松,凌立君,等.乳腺癌术后上肢淋巴水肿发生机制及预防进展[J/CD]. 中华乳腺病杂志:电子版,2013,7(6):442-445.
|
| [6] |
中国抗癌协会. 中国抗癌协会乳腺癌诊治指南与规范(2015 版)[J]. 中国癌症杂志,2015,25(9):692-754.
|
| [7] |
Wasif N, Maggard MA, Ko CY, et al. Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer[J]. Arch Surg,2010,145(2):161-166.
|
| [8] |
Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer.International Breast Cancer Study Group [ J]. Lancet, 1999,354(9182):896-900.
|
| [9] |
Nowikiewicz T,S'rutek E,Zegarski W. Application of immunohistochemistry for detection of metastases in sentinel lymph nodes of non-advanced breast cancer patients[J]. Pol J Pathol,2015,66(1):22-29.
|
| [10] |
Fitzgibbons PL,Page DL,Weaver D,et al. Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999[J]. Arch Pathol Lab Med,2000,124(7):966-978.
|
| [11] |
Colpaert C,Vermeulen P,Jeuris W,et al. Early distant relapse in“node-negative” breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour[J].J Pathol,2001,193(4):442-449.
|
| [12] |
Millis RR, Springall R, Lee AH, et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer[J]. Br J Cancer,2002,86(3):396-401.
|
| [13] |
Tan LK, Giri D, Hummer AJ, et al.Occult axillary node metastases in breast cancer are prognostically significant:results in 368 node-negative patients with 20-year follow-up[J]. J Clin Oncol,2008,26(11):1803-1809.
|
| [14] |
Chen SL,Hoehne FM,Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis[J]. Ann Surg Oncol,2007,14(12):3378-3384.
|
| [15] |
Kuijt GP, Voogd AC, van de Poll-Franse LV, et al. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients[J]. Eur J Surg Oncol,2005,31(5):500-505.
|
| [16] |
de Boer M, van Dijck JA, Bult P, et al. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases[J]. J Natl Cancer Inst,2010,102(6):410-425.
|
| [17] |
Maaskant-Braat AJ, van de Poll-Franse LV,Voogd AC,et al. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study[J]. Breast Cancer Res Treat,2011,127(1):195-203.
|
| [18] |
Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer[J]. J Clin Oncol,2009,27(28):4679-4684.
|
| [19] |
Montagna E,Viale G,Rotmensz N,et al. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure[J]. Breast Cancer Res Treat,2009,118(2):385-394.
|
| [20] |
Langer I, Guller U,Viehl CT,et al.Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in earlystage breast cancer patients: long-term outcomes of a prospective study[J]. Ann Surg Oncol,2009,16(12):3366-3374.
|
| [21] |
de Boer M, van Deurzen CH, van Dijck JA, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer[J]. N Engl J Med,2009,361(7):653-663.
|
| [22] |
Cortesi L, Proietto M, Cirilli C, et al. Prognosis and treatment of micrometastatic breast cancer sentinel lymph node: a population-based study[J]. J Surg Oncol,2012,106(4):399-405.
|
| [23] |
Cox CE,Kiluk JV,Riker AI,et al.Significance of sentinel lymph node micrometastases in human breast cancer[J]. J Am Coll Surg,2008,206(2):261-268.
|
| [24] |
Solá M, Alberro JA, Fraile M, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000 [J]. Ann Surg Oncol,2013,20 (1):120-127.
|
| [25] |
Pernas S, Gil M, Benitez A, et al. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence[J]. Ann Surg Oncol,2010,17(3):772-777.
|
| [26] |
Yegiyants S, Romero LM, Haigh PI, et al. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node[J]. Arch Surg,2010,145(6):564-569.
|
| [27] |
Galimberti V,Botteri E,Chifu C,et al.Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? [J]. Breast Cancer Res Treat,2012,131(3):819-825.
|
| [28] |
Galimberti V, Cole BF, Zurrida S, et al.Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol,2013,14(4):297-305.
|
| [29] |
Goldhirsch A, Winer EP, Coates AS, et al.Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013[J]. Ann Oncol,2013,24(9):2206-2223.
|
| [30] |
No authors listed. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group[J]. Lancet,2000,355(9217):1757-1770.
|
| [31] |
Tjan-Heijnen VC, Pepels MJ, De Boer M,et al. Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases(pN1mi) or isolated tumor cells (pN0 [i+]) in the sentinel lymph node (SN):results from the MIRROR study[EB/OL].[2015-08-01].http:/ /meeting.ascopubs.org/cgi/content/abstract/27/18S/CRA506.
|
| [32] |
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis:a randomized clinical trial[J]. JAMA,2011,305(6):569-575.
|
| [33] |
Patten DK, Leff DR, Wani Z,et al. Is the presence of small volume disease in the sentinel node an indication for axillary clearance? [J].Breast,2013,22(1):70-73.
|